Personalis Total Liabilities 2018-2023 | PSNL
Personalis total liabilities from 2018 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
Personalis Annual Total Liabilities
(Millions of US $) |
| 2023 |
$96 |
| 2022 |
$75 |
| 2021 |
$86 |
| 2020 |
$50 |
| 2019 |
$51 |
| 2018 |
$148 |
| 2017 |
$0 |
Personalis Quarterly Total Liabilities
(Millions of US $) |
| 2023-12-31 |
$96 |
| 2023-09-30 |
$75 |
| 2023-06-30 |
$73 |
| 2023-03-31 |
$79 |
| 2022-12-31 |
$75 |
| 2022-09-30 |
$75 |
| 2022-06-30 |
$93 |
| 2022-03-31 |
$94 |
| 2021-12-31 |
$86 |
| 2021-09-30 |
$81 |
| 2021-06-30 |
$45 |
| 2021-03-31 |
$47 |
| 2020-12-31 |
$50 |
| 2020-09-30 |
$45 |
| 2020-06-30 |
$52 |
| 2020-03-31 |
$53 |
| 2019-12-31 |
$51 |
| 2019-09-30 |
$48 |
| 2019-06-30 |
$75 |
| 2019-03-31 |
$0 |
| 2018-12-31 |
|
| 2018-09-30 |
$0 |
| 2018-06-30 |
$0 |
| 2017-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.078B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
